Hubei Jumpcan Pharmaceutical Co., Ltd.

SHSE:600566 Stock Report

Market Cap: CN¥24.5b

Hubei Jumpcan Pharmaceutical Future Growth

Future criteria checks 1/6

Hubei Jumpcan Pharmaceutical is forecast to grow earnings and revenue by 11.5% and 9.6% per annum respectively. EPS is expected to grow by 11.5% per annum. Return on equity is forecast to be 17.7% in 3 years.

Key information

11.5%

Earnings growth rate

11.5%

EPS growth rate

Pharmaceuticals earnings growth19.5%
Revenue growth rate9.6%
Future return on equity17.7%
Analyst coverage

Low

Last updated17 Jun 2024

Recent future growth updates

No updates

Recent updates

An Intrinsic Calculation For Hubei Jumpcan Pharmaceutical Co., Ltd. (SHSE:600566) Suggests It's 45% Undervalued

Sep 09
An Intrinsic Calculation For Hubei Jumpcan Pharmaceutical Co., Ltd. (SHSE:600566) Suggests It's 45% Undervalued

Is Hubei Jumpcan Pharmaceutical (SHSE:600566) A Risky Investment?

Aug 07
Is Hubei Jumpcan Pharmaceutical (SHSE:600566) A Risky Investment?

Is Now The Time To Put Hubei Jumpcan Pharmaceutical (SHSE:600566) On Your Watchlist?

Jul 01
Is Now The Time To Put Hubei Jumpcan Pharmaceutical (SHSE:600566) On Your Watchlist?

Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares

May 30
Hubei Jumpcan Pharmaceutical Co., Ltd.'s (SHSE:600566) Prospects Need A Boost To Lift Shares

Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Hubei Jumpcan Pharmaceutical (SHSE:600566) Ticks All The Boxes When It Comes To Earnings Growth

Earnings and Revenue Growth Forecasts

SHSE:600566 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202611,7093,773N/A3,7683
12/31/202510,8603,412N/A3,3783
12/31/202410,0423,047N/A2,6363
6/30/20249,0602,8212,5522,833N/A
3/31/20249,6692,9913,1683,501N/A
12/31/20239,6552,8233,1623,464N/A
9/30/20239,6392,5233,1563,458N/A
6/30/20239,7622,4953,1043,354N/A
3/31/20239,2112,2662,7332,916N/A
12/31/20228,9962,1712,3772,621N/A
9/30/20228,1152,0392,0802,321N/A
6/30/20227,8111,8811,8992,135N/A
3/31/20227,8881,8611,8882,172N/A
12/31/20217,6311,7191,6461,894N/A
9/30/20217,2601,5901,6721,949N/A
6/30/20216,8961,4461,4851,827N/A
3/31/20216,0741,2521,4041,805N/A
12/31/20206,1651,2771,3521,782N/A
9/30/20205,8681,2771,3041,793N/A
6/30/20205,9841,3441,7242,228N/A
3/31/20206,8681,5771,7252,231N/A
12/31/20196,9401,6231,6012,148N/A
9/30/20197,0501,6851,4631,935N/A
6/30/20197,3111,8091,2511,787N/A
3/31/20197,1601,7311,2101,781N/A
12/31/20187,2081,6881,0411,709N/A
9/30/20186,9721,6259341,753N/A
6/30/20186,6361,4847011,500N/A
3/31/20186,3651,400N/A1,399N/A
12/31/20175,6421,223N/A1,189N/A
9/30/20175,3851,165N/A1,240N/A
6/30/20175,1341,076N/A1,161N/A
3/31/20174,9261,016N/A971N/A
12/31/20164,678934N/A913N/A
9/30/20164,458864N/A764N/A
6/30/20164,249796N/A779N/A
3/31/20164,020736N/A751N/A
12/31/20153,768687N/A645N/A
9/30/20153,585640N/A688N/A
6/30/20153,392595N/A662N/A
3/31/20153,178553N/A570N/A
12/31/20142,986519N/A616N/A
9/30/20142,829490N/A589N/A
6/30/20142,664461N/A329N/A
3/31/20142,524429N/A326N/A
12/31/20132,448403N/A287N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600566's forecast earnings growth (11.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 600566's earnings (11.5% per year) are forecast to grow slower than the CN market (23.1% per year).

High Growth Earnings: 600566's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600566's revenue (9.6% per year) is forecast to grow slower than the CN market (13.2% per year).

High Growth Revenue: 600566's revenue (9.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600566's Return on Equity is forecast to be low in 3 years time (17.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y